Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements
Red Light Holland Corp. (CNSX: TRIP) (OTCMKTS: TRUFF), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles, is pleased to announce that its financial results for the year ended March 31, 2021 (“FY21”) have been filed on SEDAR. Separately, the Company has entered into a definitive agreement as part of completing its previously announced acquisition of Mera Life Sciences (“Mera”).
The Company is pleased to announce that its annual financial statements for the year ended March 31, 2021 are now available on SEDAR and highlights key data points below:
– Q4 FY21 revenue grew 535% over Q3 FY21
– During FY21, the Company realized approximately $1.3 million gain on the sale of marketable securities
– As SR Wholesale was acquired on March 19, 2021, a limited portion of SR Wholesale’s revenue could be attributed to the Company’s financial results for FY21
– Since being acquired, SR Wholesale has generated $700,000+ of revenue on an unaudited basis, a substantial portion of which is expected to be recognized on the Company’s Q2 FY22 financial results, alongside larger volumes of truffles from the second batch
– Product from the Company’s second, 1,000,000-gram harvest, was not available until after this reporting period and thus is not reflected on the Company’s FY21 results
Mera Life Sciences
The Company has also entered into a definitive agreement (the “Acquisition Agreement“), dated July 29, 2021, pursuant to which Red Light Holland will acquire 100% of the issued and outstanding shares of Mera for $2,450,000. The consideration is comprised of up to 7,000,000 common shares of the Company (the “Red Light Shares”), based on a price per Red Light Share of $0.35. The transaction is subject to several closing conditions, however the Company expects closing to take place during the first week of August, 2021. Mera is a pioneer licensee in St. Vincent and the Grenadines (“SVG”) that has spent the last 17 months working with government agencies and scientists to develop a Modern Medicinal Wellness Industry in the country.
The Red Light Shares will be released to the vendors based on the achievement of several milestones, which include: the importation of iMicrodose truffles to SVG; the approval of the transfer of the license by the government from Mera to Scarlette Lillie Sciences and Innovation; the successful prescription and sale of iMicrodose truffles to at least five patients in SVG or the successful administration of iMicrodose truffles to at least five participants in a scientific treatment study in SVG; the chemical extraction and testing of the iMicrodose truffles; the successful export of iMicrodose truffles from SVG to another jurisdiction in conformity with all national and international laws applicable to the State of St. Vincent and the Grenadines; and the final implementation of SVG’s regulatory framework for the psychedelics industry.
Mera currently holds a Medicinal Industry Development License (the “License“) issued by the SVG Bureau of Standards, which permits the research, cultivation, production, development and extraction, import and export, clinical treatment facilities, and prescribed patient access in specifically licensed clinical treatment facilities for medicinal purposes and scientific research only. The License applies to the following compounds: Turmeric, Aloe Vera, Papaya, Arrowroot, Soursop, Coconut, Ginger, Moringa, Ayahuasca, Mushroom, Iboga, Sassafras, Peyote, Psilocybin, Ibogaine, Dimethyltryptamine (DMT), Mescaline, Ketamine, 3-4 Methylenedioxy – Methamphetamine (MDMA), Lysergic Acid Diethylamide (LSD), 5-Methoxy-N,N-Dimethyltrypotomine (5-MeO-DMT). The Company has worked closely with the Ministry of Agriculture and Industry, The Bureau of Standards, Dr. Jean Saville-Cummings, molecular biologist and Professor Leonard O’Garro, Executive Director Annette Mark at Invest SVG, and the SVG government to assist in the development of the final regulatory framework which will govern the Company’s expected activities in SVG. The Company has been informed by the government of SVG that it anticipates all these regulations for the psychedelics industry (current draft in substantially final form at the Office of the Attorney General) to be made law in the near future.
This is another fantastic milestone for our company. Over the last year, we have put extensive work into laying the foundation to be the true global leader in the push to provide immediate commercial access to psychedelic substances for those in need. Our objective is to consistently demonstrate quarter on quarter revenue growth, which we did this quarter, and which we expect to materially increase into our next quarter. We are also laser focused on achieving this growth while carefully managing our operating expenses, and the fact that our cash position remains very strong indicates our success in doing so. We’ve also made great investments which have paid off meaningfully!Todd Shapiro, CEO and Director of Red Light Holland
“In closing the acquisition of Mera, we’ve also executed on two other major initiatives; accessing new markets where possible and finalizing the addition of applied sciences capabilities to our business,” added Shapiro. Having spent a significant amount of time working with the major stakeholders in St. Vincent and the Grenadines over the last six months, I am confident that this acquisition will allow us to broaden our scope for research and development, production and patient access of psychedelic compounds in groundbreaking ways. We are proud of being international pioneers and our quest to expand into progressive and emerging psychedelic markets in various countries, in my opinion, has just begun.”
Change of Auditors
The Company has changed its auditor from McGovern Hurley LLP (the “Former Auditor“) to MNP LLP (the “Successor Auditor“). The Former Auditor resigned amicably effective March 1, 2021 after the Company’s formation of Red Light Oregon. The Company’s board of directors appointed the Successor Auditor, to fill the resulting vacancy, until the close of the next annual meeting of the Company’s shareholders. The change of auditor notice required under National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102“) and associated materials are filed on SEDAR under the Company’s profile. There were no reservations or modified opinions in any auditor’s reports nor any reportable events as defined in NI 51-102 in connection with the audits by the Former Auditor of the Company’s most recently completed financial year or any subsequent period.
To view the original press release in its entirety click here